{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:14:53Z","timestamp":1786976093645,"version":"build-2736575974"},"reference-count":75,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016336","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:25:48Z","timestamp":1773231948000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Topical treatments for chronic plaque psoriasis"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1385-6839","authenticated-orcid":false,"given":"Laurence","family":"Le Cleach","sequence":"additional","affiliation":[{"name":"Department of Dermatology; H\u00f4pital Henri Mondor; Cr\u00e9teil France"},{"name":"EpiDermE (Epidemiology in Dermatology and Evaluation of therapeutics), Institut Mondor de Recherche Biom\u00e9dicale, Inserm U955; Universit\u00e9 Paris Est Cr\u00e9teil (UPEC); Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivem","family":"Afach","sequence":"additional","affiliation":[{"name":"EpiDermE (Epidemiology in Dermatology and Evaluation of therapeutics), Institut Mondor de Recherche Biom\u00e9dicale, Inserm U955; Universit\u00e9 Paris Est Cr\u00e9teil (UPEC); Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areti Angeliki","family":"Veroniki","sequence":"additional","affiliation":[{"name":"School of Public Health; Brown University; Providence RI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Berens","sequence":"additional","affiliation":[{"name":"Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Boisvert-Huneault","sequence":"additional","affiliation":[{"name":"Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Boyle","sequence":"additional","affiliation":[{"name":"Mohn Centre for Children's Health and Wellbeing, School of Public Health; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K","family":"Chu","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Health Research Methods, Evidence & Impact; McMaster University; Hamilton Canada"},{"name":"Evidence in Allergy Group; McMaster University and The Research Institute of St. Joe's Hamilton; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fahim","sequence":"additional","affiliation":[{"name":"Unity Health Toronto; Toronto, ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Guelimi","sequence":"additional","affiliation":[{"name":"Department of Dermatology; H\u00f4pital Henri Mondor; Cr\u00e9teil France"},{"name":"EpiDermE (Epidemiology in Dermatology and Evaluation of therapeutics), Institut Mondor de Recherche Biom\u00e9dicale, Inserm U955; Universit\u00e9 Paris Est Cr\u00e9teil (UPEC); Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mason","sequence":"additional","affiliation":[{"name":"Warwick Clinical Trials Unit; University of Warwick; Coventry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Salmi","sequence":"additional","affiliation":[{"name":"EpiDermE (Epidemiology in Dermatology and Evaluation of therapeutics), Institut Mondor de Recherche Biom\u00e9dicale, Inserm U955; Universit\u00e9 Paris Est Cr\u00e9teil (UPEC); Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Savinova","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Toronto; Toronto, ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Sbidian","sequence":"additional","affiliation":[{"name":"Department of Dermatology; H\u00f4pital Henri Mondor; Cr\u00e9teil France"},{"name":"EpiDermE (Epidemiology in Dermatology and Evaluation of therapeutics), Institut Mondor de Recherche Biom\u00e9dicale, Inserm U955; Universit\u00e9 Paris Est Cr\u00e9teil (UPEC); Cr\u00e9teil France"},{"name":"Clinical Investigation Centre; H\u00f4pital Henri Mondor; Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshana","family":"Seeburruth","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine; University of Toronto; University of Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Seguin","sequence":"additional","affiliation":[{"name":"Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Sidre","sequence":"additional","affiliation":[{"name":"Biblioth\u00e8que interuniversitaire de sant\u00e9 m\u00e9decine; Universit\u00e9 Paris Cit\u00e9; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Steriopoulos","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry; Western University; London, ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[{"name":"Leslie Dan School of Pharmacy; University of Toronto; Toronto, ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar","family":"Tarafdar","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry; Western University; London, ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Dimitra","family":"Bednar","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Toronto; Toronto, ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M","family":"Drucker","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Toronto and Women\u2019s College Hospital; Toronto, ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cochrane Skin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Identification, Management of Psoriasis; Associated ComorbidiTy (IMPACT) project team, Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"issue":"19","key":"10.1002\/14651858.CD016336-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"10281","key":"10.1002\/14651858.CD016336-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD016336-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1097\/MIB.0000000000001169","article-title":"Prevalence and phenotype of concurrent psoriasis and inflammatory bowel disease","volume":"23","author":"Eppinga","year":"2017","journal-title":"Inflammatory Bowel Diseases"},{"issue":"9","key":"10.1002\/14651858.CD016336-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"2112.e3","DOI":"10.1016\/j.jid.2021.02.764","article-title":"New frontiers in psoriatic disease research, part I: genetics, environmental triggers, immunology, pathophysiology, and precision medicine","volume":"141","author":"Yan","year":"2021","journal-title":"Journal of Investigative Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD016336-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.jid.2021.02.743","article-title":"New frontiers in psoriatic disease research, part II: comorbidities and targeted therapies","volume":"141","author":"Blauvelt","year":"2021","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD016336-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2014.530","article-title":"The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries","volume":"135","author":"Dalgard","year":"2015","journal-title":"Journal of Investigative Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD016336-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/jid.2013.508","article-title":"The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis","volume":"134","author":"Dowlatshahi","year":"2014","journal-title":"Journal of Investigative Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD016336-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jaad.2015.02.1127","article-title":"Genital psoriasis is associated with significant impairment in quality of life and sexual functioning","volume":"72","author":"Ryan","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD016336-BIB0011|cit11","unstructured":"Nast A Spuls PI Dressler C Bata-Cs\u00f6rg\u00f6 Z Bogdanov I Boonen H Living EuroGuiDerm guideline for the systemic treatment of psoriasis vulgaris Available from https:\/\/www.guidelines.edf.one\/guidelines\/psoriasis-guideline"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD016336-BIB0013|cit13","unstructured":"National Institute for Health and Care Excellence (NICE) Psoriasis: assessment and management, clinical guideline. CG153 [last updated September 2017] Available from https:\/\/www.nice.org.uk\/guidance\/cg153"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: a European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Archives of Dermatological Research"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","article-title":"Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council","volume":"82","author":"Strober","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD016336-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005028.pub3","article-title":"Topical treatments for chronic plaque psoriasis","author":"Mason","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD016336-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jama.2022.15632","article-title":"Effect of roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials","volume":"328","author":"Lebwohl","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaad.2019.06.1288","article-title":"Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: a double-blind, randomized, vehicle-controlled trial","volume":"82","author":"Hashim","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"24","key":"10.1002\/14651858.CD016336-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2103629","article-title":"Phase 3 trials of tapinarof cream for plaque psoriasis","volume":"385","author":"Lebwohl","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD016336-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jaad.2011.12.018","article-title":"Preliminary clinical activity of a topical JAK1\/2 inhibitor in the treatment of psoriasis","volume":"67","author":"Punwani","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12895-016-0051-4","article-title":"Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a phase 2b randomized clinical trial","volume":"16","author":"Papp","year":"2016","journal-title":"BMC Dermatology"},{"issue":"10451","key":"10.1002\/14651858.CD016336-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(24)01027-4","article-title":"Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials","volume":"404","author":"Bissonnette","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD016336-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","article-title":"Psoriasis prevalence and severity by expert elicitation","volume":"11","author":"Papp","year":"2021","journal-title":"Dermatology and Therapy"},{"issue":"10","key":"10.1002\/14651858.CD016336-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD016336-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011535.pub6","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","author":"Sbidian","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD016336-BIB0026|cit26","unstructured":"Higgins JPT Lasserson T Chandler J Tovey D Churchill R Methodological Expectations of Cochrane Intervention Reviews . Cochrane: London, Version August 2023 Available from community.cochrane.org\/mecir-manual"},{"issue":"11","key":"10.1002\/14651858.CD016336-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reportingof systematic reviews incorporating network meta-analyses ofhealth care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD016336-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"15\u201319","DOI":"10.1080\/095466300750163717","article-title":"Scholtz-Dumas psoriasis small plaque bioassay","volume":"11","author":"Katz","year":"2000","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD016336-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jid.2020.03.945","article-title":"Research techniques made simple: randomized controlled trials for topical drugs in dermatology: when and how should we use a within-person design?","volume":"140","author":"Leducq","year":"2020","journal-title":"Journal of Investigative Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD016336-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/jamadermatol.2022.1706","article-title":"Agreement and correlation between different topical corticosteroid potency classification systems","volume":"158","author":"Bowie","year":"2022","journal-title":"JAMA Dermatology"},{"key":"10.1002\/14651858.CD016336-BIB0032|cit32","first-page":"38","volume-title":"Hurwitz Clinical Pediatric Dermatology. A Textbook of Skin Disorders of Childhood and Adolescence","author":"Paller","year":"2015"},{"issue":"10","key":"10.1002\/14651858.CD016336-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamadermatol.2018.1165","article-title":"Identifying a core domain set to assess psoriasis in clinical trials","volume":"154","author":"Callis","year":"2018","journal-title":"JAMA Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD016336-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/bjd.13691","article-title":"Patient-reported outcome measures in psoriasis: the good, the bad and the missing!","volume":"172","author":"Kitchen","year":"2015","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD016336-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000083509","article-title":"The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis","volume":"210","author":"Schmitt","year":"2005","journal-title":"Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD016336-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) \u2212 a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clinical and Experimental Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD016336-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/jamadermatol.2023.5439","article-title":"Patient-reported outcome measures for health-related quality of life in patients with psoriasis: a systematic review","volume":"160","author":"P\u00e9rez-Chada","year":"2024","journal-title":"JAMA Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD016336-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/jid.2009.391","article-title":"How good are clinical severity and outcome measures for psoriasis? Quantitative evaluation in a systematic review","volume":"130","author":"Spuls","year":"2010","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD016336-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40257-019-00458-2","article-title":"Feasibility and utility of the psoriasis symptom inventory (PSI) in clinical care settings: a study from the international psoriasis council","volume":"20","author":"Strober","year":"2019","journal-title":"American Journal of Clinical Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jid.2021.06.032","article-title":"Measurement properties of patient-reported outcome measures for pruritus: an updated systematic review","volume":"142","author":"Topp","year":"2022","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD016336-BIB0041|cit41","unstructured":"European Medicines Agency International Conference on Harmonisation (ICH) technical requirements for registration of pharmaceuticals for human use. Topic E2: Clinical safety data management: Definitions and standards for expedited reporting. CPMP\/ICH\/377\/95. London, June 1995 https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-topic-e-2-clinical-safety-data-management-definitions-and-standards-expedited-reporting-step_en.pdf"},{"key":"10.1002\/14651858.CD016336-BIB0042|cit42","unstructured":"Living Evidence Network Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode Available from community.cochrane.org\/review-production\/production-resources\/living-systematic-reviews#guidance"},{"key":"10.1002\/14651858.CD016336-BIB0043|cit43","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Technical Supplement to Chapter 4: Searching for and selecting studies [last updated March 2025]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1. Cochrane, 2025 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016336-BIB0044|cit44","unstructured":"Zotero Corporation for Digital Scholarship 2026"},{"key":"10.1002\/14651858.CD016336-BIB0045|cit45","unstructured":"Covidence Veritas Health Innovation 2025"},{"key":"10.1002\/14651858.CD016336-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"111406","DOI":"10.1016\/j.jclinepi.2024.111406","article-title":"Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review","volume":"173","author":"Beytout","year":"2024","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016336-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12916-015-0430-4","article-title":"Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles","volume":"13","author":"Tang","year":"2015","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD016336-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD016336-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD016336-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"336\u201351","DOI":"10.1002\/jrsm.1310","article-title":"Dealing with effect size multiplicity in systematic reviews and meta-analyses","volume":"9","author":"L\u00f3pez-L\u00f3pez","year":"2018","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD016336-BIB0051|cit51","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016336-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"96\u2013107","DOI":"10.1002\/jrsm.1130","article-title":"Simultaneous synthesis of treatment effects and mapping to a common scale: an alternative to standardisation","volume":"6","author":"Ades","year":"2015","journal-title":"Research Synthesis Methods"},{"issue":"26","key":"10.1002\/14651858.CD016336-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1002\/sim.9562","article-title":"Network meta-analysis of rare events using penalized likelihood regression","volume":"41","author":"Evrenoglou","year":"2022","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016336-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jclinepi.2016.02.016","article-title":"The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes","volume":"76","author":"Veroniki","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD016336-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/sim.6365","article-title":"Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis","volume":"34","author":"Mavridis","year":"2015","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD016336-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1740774512470317","article-title":"Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis","volume":"10","author":"Spineli","year":"2013","journal-title":"Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD016336-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/ije\/dyt074","article-title":"Effects of study precision and risk of bias in networks of interventions: a network meta-epidemiological study","volume":"42","author":"Chaimani","year":"2013","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD016336-BIB0060|cit60","unstructured":"Deeks JJ Higgins JPT Altman DG McKenzie JE Chapter 10: Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jrsm.1319","article-title":"Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis","volume":"10","author":"Veroniki","year":"2019","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD016336-BIB0062|cit62","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"issue":"7-8","key":"10.1002\/14651858.CD016336-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"4","key":"10.1002\/14651858.CD016336-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLOS Medicine"},{"issue":"7","key":"10.1002\/14651858.CD016336-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD016336-BIB0067|cit67","unstructured":"R: a language and environment for statistical computing R Foundation for Statistical Computing 2024"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1\u201340","DOI":"10.18637\/jss.v106.i02","article-title":"Netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"Journal of Statistical Software"},{"key":"10.1002\/14651858.CD016336-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"issue":"32","key":"10.1002\/14651858.CD016336-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"issue":"3","key":"10.1002\/14651858.CD016336-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinepi.2014.08.012","article-title":"Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data","volume":"68","author":"Rhodes","year":"2015","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD016336-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD016336-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nunez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD016336-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005028.pub2","article-title":"Topical treatments for chronic plaque psoriasis","author":"Mason","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:25:53Z","timestamp":1773231953000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016336"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":75,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016336","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}